Ascendis Pharma A/S (ASND) Q3 2024 Earnings

14NovConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-2.5
-2.17
-1.85
-1.52

Details

Expected EPS
-1.52
Actual EPS
-1.89
Surprise EPS
-0.37
Surprise Percent
+24.34%

Description

Ascendis Pharma A/S (ASND) has reported earnings of -1.89 per share for Q3 2024.

0 Comments

Share your thoughts